- Home
- NVCT vs NAUT Comparison
NVCT vs NAUT Comparison
Compare NVCT & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- NAUT
- Stock Information
- Founded
- NVCT 2020
- NAUT 2016
- Country
- NVCT United States
- NAUT United States
- Employees
- NVCT N/A
- NAUT N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- NVCT Health Care
- NAUT Industrials
- Exchange
- NVCT Nasdaq
- NAUT Nasdaq
- Market Cap
- NVCT 170.3M
- NAUT 188.3M
- IPO Year
- NVCT 2022
- NAUT N/A
- Fundamental
- Price
- NVCT $8.87
- NAUT $0.76
- Analyst Decision
- NVCT Strong Buy
- NAUT Hold
- Analyst Count
- NVCT 3
- NAUT 3
- Target Price
- NVCT $15.67
- NAUT $3.58
- AVG Volume (30 Days)
- NVCT 128.2K
- NAUT 174.6K
- Earning Date
- NVCT 05-06-2025
- NAUT 04-29-2025
- Dividend Yield
- NVCT N/A
- NAUT N/A
- EPS Growth
- NVCT N/A
- NAUT N/A
- EPS
- NVCT N/A
- NAUT N/A
- Revenue
- NVCT N/A
- NAUT N/A
- Revenue This Year
- NVCT N/A
- NAUT N/A
- Revenue Next Year
- NVCT N/A
- NAUT N/A
- P/E Ratio
- NVCT N/A
- NAUT N/A
- Revenue Growth
- NVCT N/A
- NAUT N/A
- 52 Week Low
- NVCT $4.44
- NAUT $0.66
- 52 Week High
- NVCT $11.80
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- NVCT 51.36
- NAUT 38.87
- Support Level
- NVCT $8.70
- NAUT $0.72
- Resistance Level
- NVCT $10.19
- NAUT $0.83
- Average True Range (ATR)
- NVCT 0.93
- NAUT 0.11
- MACD
- NVCT -0.08
- NAUT 0.02
- Stochastic Oscillator
- NVCT 40.45
- NAUT 39.20
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.